Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BRCA Status”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableLooking for participantsNCT06111417
What this trial is testing

Use of an Ultra-rapid BRCA1/2 Status Screening Test in Diagnostic and Theranostic Indication: Performance and Interest for Patients and Practitioners

Who this might be right for
Breast Cancer
Centre Georges Francois Leclerc 150
Testing effectiveness (Phase 2)Study completedNCT02983799
What this trial is testing

Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status

Who this might be right for
Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity
AstraZeneca 272
Not applicableStudy completedNCT02222883
What this trial is testing

Prevalence of BRCA in Patients With Ovarian Cancer

Who this might be right for
BRCA StatusOvarian Cancer
AGO Research GmbH 530
Not applicableNot Yet RecruitingNCT07699913
What this trial is testing

Quality of Life of Patients Who Have Undergone Bilateral Mastectomy

Who this might be right for
Surgery DateAgeBMI+11 more
University Hospital, Grenoble 115
Not applicableStudy completedNCT04012229
What this trial is testing

IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)

Who this might be right for
Breast CancerBRCA1 MutationBRCA2 Mutation
Centre Hospitalier Universitaire de Besancon 2,295
Not applicableUnknownNCT06304922
What this trial is testing

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

Who this might be right for
Ovarian Cancer
Assiut University 45
Not applicableStudy completedNCT05775549
What this trial is testing

Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

Who this might be right for
Advanced Ovarian Cancer
AstraZeneca 24
Not applicableStudy completedNCT04073693
What this trial is testing

Characterization of the Nutritional Status in the Patient With Liver Cirrhosis

Who this might be right for
Sarcopenia
Puerta de Hierro University Hospital 32
Not applicableStudy completedNCT00858078
What this trial is testing

A Qualitative Exploration of the Impact of Positive BRCA1/2 Mutation Status on the Lives of Young Women

Who this might be right for
BRCA1 GeneBRCA2 Gene
National Cancer Institute (NCI) 76
Testing effectiveness (Phase 2)Looking for participantsNCT05183984
What this trial is testing

Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer

Who this might be right for
Ovarian Cancer
ARCAGY/ GINECO GROUP 390
Large-scale testing (Phase 3)Not Yet RecruitingNCT07628504
What this trial is testing

Sac-TMT Sequential Capecitabine Versus Capecitabine in Early-Stage High-Risk Triple-Negative Breast Cancer Without BRCA Mutations

Who this might be right for
Adjuvant Drug Therapy
Fudan University 420
Not applicableStudy completedNCT05750719
What this trial is testing

BRCA and NACT in TNBC Patients

Who this might be right for
Triple-Negative Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 136
Not applicableEnded earlyNCT03203993
What this trial is testing

China Ovarian Cancer BRCA Testing Study

Who this might be right for
Ovarian Cancer
AstraZeneca 29
Testing effectiveness (Phase 2)Study completedNCT00679783
What this trial is testing

Phase II Study of AZD2281 in Patients With Known BRCA Mutation Status or Recurrent High Grade Ovarian Cancer or Patients With Known BRCA Mutation Status/ Triple Neg Breast Cancer

Who this might be right for
Ovarian CarcinomaBreast Cancer
AstraZeneca 99
Testing effectiveness (Phase 2)Active Not RecruitingNCT04053322
What this trial is testing

Durvalumab, With Olaparib and Fulvestrant in Advanced ER+, HER2- Breast Cancer Patients.

Who this might be right for
ER-positive and HER2-negative Metastatic or Locally Advanced Breast Cancera Germline or Somatic BRCA Mutation, or a Deleterious Alteration of Other Genes Involved in Homologous Recombination Repair (HRR) or in MSI Status
UNICANCER 172
Testing effectiveness (Phase 2)Study completedNCT01690598
What this trial is testing

Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status

Who this might be right for
Ovarian Cancer
Vejle Hospital 22
Not applicableUnknownNCT04651933
What this trial is testing

A Training Set for the HRD Model in EOC

Who this might be right for
Epithelial Ovarian CancerBRCA MutationLoss of Heterozygosity+3 more
Lei Li 200